Here, it is elucidated that CYP4X1/sEH-dependent endocannabinoid metabolism governs immune evasion in colon cancer by promoting the infiltration of regulatory T cells (Tregs) and impairing CD8<sup>+</sup> T cell effector function. The gene discussed is EPHX2; the disease is colonic neoplasm.